Insider Transactions in Q2 2022 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
230
+0.31%
|
-
|
|
Jun 30
2022
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
346
+0.92%
|
-
|
|
Jun 30
2022
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
533
+50.0%
|
-
|
|
Jun 30
2022
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
230
+11.97%
|
-
|
|
Jun 30
2022
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
374
+11.02%
|
-
|
|
Jun 30
2022
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
230
+0.01%
|
-
|
|
May 26
2022
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
950
-2.74%
|
$16,150
$17.1 P/Share
|
|
May 24
2022
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,362
-5.95%
|
$23,154
$17.1 P/Share
|
|
May 24
2022
|
George Gauthier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,340
-5.04%
|
$22,780
$17.1 P/Share
|
|
May 24
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
939
-2.32%
|
$15,963
$17.1 P/Share
|
|
May 24
2022
|
Fred Schwarzer CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,362
-3.85%
|
$23,154
$17.1 P/Share
|
|
May 24
2022
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
938
-2.48%
|
$15,946
$17.1 P/Share
|
|
May 20
2022
|
Jakob Haldor Topsoe |
BUY
Open market or private purchase
|
Direct |
1,481
+1.98%
|
$23,696
$16.0 P/Share
|
|
May 13
2022
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
413
+1.77%
|
$4,956
$12.38 P/Share
|
|
May 13
2022
|
George Gauthier Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
413
+1.53%
|
$4,956
$12.38 P/Share
|
|
May 13
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
413
+1.01%
|
$4,956
$12.38 P/Share
|
|
May 13
2022
|
Fred Schwarzer CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
414
+1.16%
|
$4,968
$12.38 P/Share
|
|
May 13
2022
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
391
+1.12%
|
$4,692
$12.38 P/Share
|
|
May 13
2022
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
825
+2.14%
|
$9,900
$12.38 P/Share
|
|
May 13
2022
|
Christina Teng Topsoe |
BUY
Open market or private purchase
|
Indirect |
4,510
+39.88%
|
$63,140
$14.99 P/Share
|
|
May 13
2022
|
Jakob Haldor Topsoe |
BUY
Open market or private purchase
|
Direct |
7,850
+9.83%
|
$109,900
$14.86 P/Share
|
|
May 12
2022
|
Christina Teng Topsoe |
BUY
Open market or private purchase
|
Indirect |
2,290
+50.0%
|
$32,060
$14.08 P/Share
|
|
May 12
2022
|
Jakob Haldor Topsoe |
BUY
Open market or private purchase
|
Direct |
8,254
+11.4%
|
$115,556
$14.17 P/Share
|
|
Apr 08
2022
|
Michael D Loberg Director |
BUY
Bona fide gift
|
Indirect |
533
+2.34%
|
-
|
|
Apr 08
2022
|
Michael D Loberg Director |
SELL
Bona fide gift
|
Direct |
533
-100.0%
|
-
|
|
Apr 06
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,500
-5.88%
|
$62,500
$25.0 P/Share
|
|
Apr 06
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+5.55%
|
$0
$0.93 P/Share
|
|
Apr 01
2022
|
M Kathleen Behrens |
BUY
Open market or private purchase
|
Indirect |
60,869
+22.24%
|
$1,399,987
$23.0 P/Share
|
|
Apr 01
2022
|
Michael D Loberg Director |
BUY
Open market or private purchase
|
Indirect |
21,739
+50.0%
|
$499,997
$23.0 P/Share
|